Header menu link for other important links
X
Development and validation of a RP-HPLC-PDA method for simultaneous determination of lornoxicam and thiocolchicoside in pharmaceutical dosage form and its application for dissolution study
M. Sahoo, P. Syal, S. Ingale, K. Ingale, S. Sindhe, M. Sali, ,
Published in
2011
Volume: 2
   
Issue: 1
Pages: 1 - 7
Abstract
A simple, selective, rapid, and precise RP-HPLC-PDA method has been developed for the simultaneous estimation of Lornoxicam (LOR) and Thiocolchicoside (THIO) in pharmaceutical dosage form by reverse phase liquid chroma-tography using Waters Symmetry C18 (250 mm × 4.6 mm, 5.0 μ) column. The mobile phase consisting of metha-nol: THF: acetate buffer (60: 10: 30 v/v); pH adjusted to 5.5 with glacial acetic acid at a flow rate of 0.75 mL min-1 and column was maintained at 50 °C with detection at 382 nm. The retention time of Thiocolchicoside and Lornox-icam was 3.36 and 4.08 minutes, respectively. The method was validated according to the ICH guidelines with re-spect to specificity, linearity, accuracy, precision and robustness, limit of detection and limit of quantification. Li-nearity of Lornoxicam and Thiocolchicoside were in the range of 0.2 to 80 μg mL-1 and 0.1 to 40 μg mL-1, respec-tively and its percentage recovery were found to be 100.37 % and 100.51 %, respectively. The proposed method is suitable for simultaneous determination of Lornoxicam and Thiocolchicoside in pharmaceutical dosage form. Me-thod was successfully applied for dissolution study of tablet formulation. ©JK Welfare & Pharmascope Foundation.
About the journal
JournalInternational Journal of Research in Pharmaceutical Sciences
ISSN09757538